SubHero Banner
Text

Jubbonti® (denosumab-bbdz) – First-time interchangeable biosimilar launch

June 2, 2025 - Sandoz launched Jubbonti (denosumab-bbdz), biosimilar and interchangeable to Amgen’s Prolia® (denosumab).

Download PDF

Text